MBX Biosciences MBX Growth Metrics (2023-2026)

NASDAQ MBX
$54.44 +0.94 (+1.77%)
As of: Oct 21, 2026 · 11:41 AM EDT
Reported Financials

MBX Biosciences Quarterly Growth Metrics

Periods 11 quarters
Latest Jun 2026

MBX Biosciences reported asset growth of 88.28% for the quarter ended Jun 2026. These growth metrics cover 11 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) 219.00%41.67%43.42%84.08%88.28%
Assets (QoQ) -4.91%-8.42%-5.86%72.80%-3.73%17.54%-3.71%
Capital Expenditures Growth (1y)Capex Growth (1y) 67.27%-89.01%56.42%600.00%761.96%1,356.67%27.44%
Capital Expenditures (QoQ)Capex (QoQ) 396.36%65.57%-87.39%61.40%-67.39%2,256.67%-43.56%98.75%-44.89%106.18%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 61.68%67.93%52.56%51.20%36.05%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -62.86%-39.41%33.03%460.88%-66.26%-39.95%19.71%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -132.59%-79.09%429.31%116.92%-93.00%-3,109.83%12.41%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 153.29%-151.14%-1,177.25%33.18%104.79%705.52%-34.36%-862.04%25.29%130.08%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -43.88%-111.75%-31.38%-46.86%-14.12%10.89%-29.76%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 3.91%-23.90%-10.50%-9.36%-41.41%23.12%-23.53%15.02%-10.42%-11.95%
EBIT Growth (1y) -79.19%-86.27%-99.26%-30.90%-22.00%-38.61%-2.77%-87.71%
EBIT (QoQ) 8.72%-33.26%-25.12%-17.73%5.11%-42.55%17.81%-9.73%-7.81%-5.70%-50.12%
EBT Growth (1y) -78.53%-76.25%-93.56%-22.41%-19.16%-41.55%1.52%-91.10%
EBT (QoQ) 12.98%-39.51%-28.53%-14.41%14.09%-53.21%18.71%-11.37%-2.05%-6.60%-57.74%
EPS (Basic) Growth (1y) 70.37%83.13%93.03%95.40%77.30%58.73%29.35%-34.01%
EPS (Basic) (QoQ) 7.63%-18.20%-22.99%77.94%47.41%51.20%18.80%-8.92%4.40%16.45%-54.03%
EPS (Diluted) Growth (1y) 70.37%83.13%93.03%95.40%77.30%58.73%29.35%-34.01%
EPS (Diluted) (QoQ) 7.63%-18.20%-22.99%77.94%47.41%51.20%18.80%-8.92%4.40%16.45%-54.03%
Free Cash Flow Growth (1y)FCF Growth (1y) -44.00%-106.76%-32.20%-49.00%-18.38%9.08%-29.67%
Free Cash Flow (QoQ)FCF (QoQ) 1.95%-24.94%-7.28%-9.56%-40.79%20.11%-20.91%12.95%-8.12%-13.94%
Net Cash Flow Growth (1y)NCF Growth (1y) -108.36%-496.74%143.09%52.33%-77.02%-53.59%-9.81%
Net Cash Flow (QoQ)NCF (QoQ) 112.23%-567.61%625.09%-169.39%76.71%150.79%1,756.08%-180.63%79.80%129.83%
Net Income Growth (1y) -78.53%-76.25%-93.56%-22.41%-19.16%-41.55%1.52%-91.10%
Net Income (QoQ) 12.98%-39.51%-28.53%-14.41%14.09%-53.21%18.71%-11.37%-2.05%-6.60%-57.74%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -78.53%-76.25%-93.56%-22.41%-19.16%-41.55%1.52%-91.10%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 12.98%-39.51%-28.53%-14.41%14.09%-53.21%18.71%-11.37%-2.05%-6.60%-57.74%
Operating Income Growth (1y)Op. Inc Growth (1y) -79.19%-86.27%-99.26%-30.90%-22.00%-38.61%-2.77%-87.71%
Operating Income (QoQ)Op. Inc (QoQ) 8.72%-33.26%-25.12%-17.73%5.11%-42.55%17.81%-9.73%-7.81%-5.70%-50.12%
Profit After Tax Growth (1y)PAT Growth (1y) -78.53%-76.25%-93.56%-22.41%-19.16%-41.55%1.52%-91.10%
Profit After Tax (QoQ)PAT (QoQ) 12.98%-39.51%-28.53%-14.41%14.09%-53.21%18.71%-11.37%-2.05%-6.60%-57.74%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 146.01%94.00%153.24%107.62%169.54%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 4.55%39.72%14.65%15.84%36.48%14.55%48.83%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 33.00789.00879.00
Return on Assets [ROA] (QoQ)ROA (QoQ) -608.00-370.00677.00334.00148.00-280.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -21.00856.000.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -720.00-514.00822.00392.00157.00-360.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 0.00M43.00835.00926.00
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.00M-639.00-407.00735.00355.00152.00-315.00
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 46.17%13.31%110.77%88.34%78.49%198.21%213.06%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 59.43%-43.38%29.71%24.83%23.59%5.33%15.90%18.31%106.48%10.58%

MBX Biosciences Growth Metrics API

Pull MBX Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MBX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY